TargetGene Biotechnologies Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Corporate
- Financing Rounds
-
1
TargetGene Biotechnologies General Information
Description
Provider of a therapeutic DNA editing platform intended to enable precise genetic modification for the treatment of multiple diseases. The company offers in vivo and ex vivo gene editing capabilities through collaborative development partnerships, enabling biotechnology and pharmaceutical companies to advance cell and gene therapies across diverse disease indications.
Contact Information
Website
WWW.targetgenebio.comCorporate Office
- Oppenheimer 10
- Floor 4
- Rehovot
- Israel
Corporate Office
- Oppenheimer 10
- Floor 4
- Rehovot
- Israel
TargetGene Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TargetGene Biotechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
TargetGene Biotechnologies Patents
TargetGene Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022386792-A1 | Systems and methods for trans-modulation of immune cells by genetic manipulation of immune regulatory genes | Inactive | 12-Nov-2021 | ||
| CA-3235955-A1 | Systems and methods for trans-modulation of immune cells by genetic manipulation of immune regulatory genes | Pending | 12-Nov-2021 | ||
| EP-4429677-A1 | Systems and methods for trans-modulation of immune cells by genetic manipulation of immune regulatory genes | Pending | 12-Nov-2021 | ||
| EP-4429677-A4 | Systems and methods for trans-modulation of immune cells by genetic manipulation of immune regulatory genes | Pending | 12-Nov-2021 | ||
| US-20250032542-A1 | Systems and methods for trans-modulation of immune cells by genetic manipulation of immune regulatory genes | Pending | 12-Nov-2021 | A61K35/17 |
TargetGene Biotechnologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
TargetGene Biotechnologies Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
TargetGene Biotechnologies FAQs
-
When was TargetGene Biotechnologies founded?
TargetGene Biotechnologies was founded in 2012.
-
Where is TargetGene Biotechnologies headquartered?
TargetGene Biotechnologies is headquartered in Rehovot, Israel.
-
What is the size of TargetGene Biotechnologies?
TargetGene Biotechnologies has 6 total employees.
-
What industry is TargetGene Biotechnologies in?
TargetGene Biotechnologies’s primary industry is Biotechnology.
-
Is TargetGene Biotechnologies a private or public company?
TargetGene Biotechnologies is a Private company.
-
What is TargetGene Biotechnologies’s current revenue?
The current revenue for TargetGene Biotechnologies is .
-
Who are TargetGene Biotechnologies’s investors?
Monsanto has invested in TargetGene Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
